Adial Pharmaceuticals WT Valuation
| ADILWDelisted Stock | USD 0.01 0 52.50% |
Adial Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Adial Pharmaceuticals from analyzing the firm fundamentals such as Retained Earnings of (63.67 M), number of shares shorted of 506, and Net Income of (12.73 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Adial Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Adial Pharmaceuticals is based on 3 months time horizon. Increasing Adial Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Adial stock is determined by what a typical buyer is willing to pay for full or partial control of Adial Pharmaceuticals WT. Since Adial Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Adial Stock. However, Adial Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0061 | Real 0.005795 | Hype 0.008296 | Naive 0.00474 |
The intrinsic value of Adial Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Adial Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Adial Pharmaceuticals WT helps investors to forecast how Adial stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Adial Pharmaceuticals more accurately as focusing exclusively on Adial Pharmaceuticals' fundamentals will not take into account other important factors: Adial Pharmaceuticals Total Value Analysis
Adial Pharmaceuticals WT is presently expected to have takeover price of 0 with market capitalization of 0, debt of 207.38 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Adial Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the companyAdial Pharmaceuticals Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Adial indicates not a very effective usage of assets in December.Adial Pharmaceuticals Profitability Analysis
Net Loss for the year was (12.73 M) with profit before overhead, payroll, taxes, and interest of 0.About Adial Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Adial Pharmaceuticals. We calculate exposure to Adial Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Adial Pharmaceuticals's related companies.Adial Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Adial Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Adial Stock
If you are still planning to invest in Adial Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adial Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |